Outcome indicators in the different phases of the study
| Phase I | Phase II | Phase III | |
| Total central line insertions observed | 33 | 63 | 51 |
| Total central line days | 187 | 450 | 392 |
| Total no of patient-days | 1002 | 1834 | 1874 |
| LONS/1000 patient-days | 12 | 6.95 | 6.8 |
| Total CLABSI episodes | 3 | 4 | 4 |
| CLABSI rate/1000 central line days | 16.04 | 8.8 | 10.2 |
| % of LONS accounted by CLABSI | 25% | 31% | 31% |
| CLABSI/1000 patient-days | 2.99 | 2.17 | 2.13 |
| Mortality rate/1000 patient-days | 7.4 | 6.25 | 8.3 |
CLABSI, central line associated bloodstream infection; LONS, late-onset neonatal sepsis.